Palvella completes pre-NDA meeting with FDA for rapamycin gel

Palvella completes pre-NDA meeting with FDA for rapamycin gel

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.